Understanding Antibiotics and Antimicrobial Resistance

Antibiotics have transformed healthcare by enabling medical advances and saving lives. However, antimicrobial resistance (AMR) poses a significant threat, potentially causing 10 million deaths annually by 2050. Pfizer is committed to combating AMR through diverse solutions, including expanding anti-infective medicines, enhancing the ATLAS surveillance program, and promoting antimicrobial stewardship. ATLAS monitors bacterial resistance globally, providing valuable data to healthcare practitioners. Responsible antibiotic use and vaccination are crucial in reducing AMR. Collaboration between governments, public health communities, and industry is essential to develop new antibiotics and vaccines.

What medical advances have antibiotics enabled?

• Surgical procedures and organ transplants

• Genetic engineering

• Cancer prevention

• Viral infection treatments

What is a major consequence of pathogens developing resistance to antibiotics?

• Improved global health

• Increased effectiveness of antibiotics

• Development of superbugs

• Decrease in bacterial infections

How many deaths are currently attributed to AMR annually?

• 500,000

• 10 million

• 1 million

• 700,000

What is one of Pfizer's strategies to combat AMR?

• Reducing the production of antibiotics

• Expanding their portfolio of anti-infective medicines

• Eliminating the use of vaccines

• Focusing solely on viral infections

What does the ATLAS program aim to achieve?

• Monitor real-time changes in bacterial resistance

• Reduce the number of hospitals participating

• Focus only on developed countries

• Increase the use of antibiotics

How many hospitals contribute data to the ATLAS program?

• 1000

• 760

• 1500

• 500

What is a key practice to reduce the spread of AMR?

• Avoiding vaccinations

• Applying greater oversight of antibiotic usage

• Increasing antibiotic prescriptions

• Ignoring resistance patterns

What should individuals do when prescribed antibiotics?

• Take them only when convenient

• Finish the entire course

• Stop taking them once symptoms improve

• Share them with others

How do vaccines contribute to reducing AMR?

• By eliminating the need for hygiene practices

• By preventing infections and reducing antibiotic use

• By increasing the need for antibiotics

• By causing more bacterial infections

What is necessary for continued innovation in antibiotic development?

• Focusing only on existing antibiotics

• Isolating pharmaceutical companies

• Reducing research funding

• Collaboration between governments and industry